Nymox Pharmaceutical
NYMX
#10168
Rank
C$24.95 M
Marketcap
Country
C$0.27
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -C$2.93 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -C$8.93 Million, an increase over its 2021 earnings that were of -C$17.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$2.93 Million-67.26%
2022 -C$8.93 Million-47.71%
2021 -C$17.07 Million6.61%
2020 -C$16.01 Million-10.91%
2019 -C$17.97 Million24.24%
2018 -C$14.46 Million-20.03%
2017 -C$18.08 Million2.71%
2016 -C$17.61 Million-63.86%
2015 -C$48.71 Million674.44%
2014 -C$6.29 Million-6.11%
2013 -C$6.7 Million-35.66%
2012 -C$10.42 Million-20.76%
2011 -C$13.15 Million38.33%
2010 -C$9.5 Million35.59%
2009 -C$7.01 Million11.8%
2008 -C$6.27 Million-12.94%
2007 -C$7.2 Million8.85%
2006 -C$6.62 Million36.5%
2005 -C$4.85 Million-4.4%
2004 -C$5.07 Million-14.58%
2003 -C$5.94 Million
2001 -C$4.36 Million-20.54%
2000 -C$5.48 Million21.72%
1999 -C$4.5 Million-25.56%
1998 -C$6.05 Million101.3%
1997 -C$3.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
C$11.12 B-376,684.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.20 B-548,549.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$1.75 B-59,655.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$30.76 B-1,041,451.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.28 B-1,499,220.78%๐Ÿ‡บ๐Ÿ‡ธ USA